These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Trends in the development of therapeutic anti-cytokine antibodies. Reichert JM Drug Discov Today; 2004 Apr; 9(8):348. PubMed ID: 15081960 [No Abstract] [Full Text] [Related]
23. T cell targeted immunotherapy for autoimmune disease. Lee E; Sinha AA Autoimmunity; 2005 Dec; 38(8):577-96. PubMed ID: 16390811 [TBL] [Abstract][Full Text] [Related]
24. Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer. Bizzini B; Drouet B; Zagury D; Abitbol M; Burny A; Boissier MC Immunotherapy; 2010 May; 2(3):347-65. PubMed ID: 20635900 [TBL] [Abstract][Full Text] [Related]
25. ABT-874, a fully human monoclonal anti-IL-12/IL-23 antibody for the potential treatment of autoimmune diseases. Ding C; Xu J; Li J Curr Opin Investig Drugs; 2008 May; 9(5):515-22. PubMed ID: 18465662 [TBL] [Abstract][Full Text] [Related]
26. [Anti-B-cell strategies in autoimmune diseases]. Müller-Ladner U Z Rheumatol; 2009 Jul; 68(5):363. PubMed ID: 19513728 [No Abstract] [Full Text] [Related]
28. Optimization and delivery of plasmid DNA for vaccination. Jechlinger W Expert Rev Vaccines; 2006 Dec; 5(6):803-25. PubMed ID: 17184219 [TBL] [Abstract][Full Text] [Related]
29. Vaccines for lymphomas: idiotype vaccines and beyond. Houot R; Levy R Blood Rev; 2009 May; 23(3):137-42. PubMed ID: 18951668 [TBL] [Abstract][Full Text] [Related]
30. [A chimeric cytokine to help autoimmune diseases]. Rafei M; Galipeau J Med Sci (Paris); 2010 Feb; 26(2):137-9. PubMed ID: 20188040 [No Abstract] [Full Text] [Related]
31. Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells. Silva HM; Vieira PM; Costa PL; Pimentel BM; Moro AM; Kalil J; Maranhão AQ; Coelho V; Brigido MM Immunol Lett; 2009 Aug; 125(2):129-36. PubMed ID: 19573559 [TBL] [Abstract][Full Text] [Related]
35. Understanding autoimmune disease: new targets for drug discovery. Balagué C; Kunkel SL; Godessart N Drug Discov Today; 2009 Oct; 14(19-20):926-34. PubMed ID: 19596080 [TBL] [Abstract][Full Text] [Related]
36. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt? Jorgensen C; Apparailly F; Sany J Ann Rheum Dis; 1999 Mar; 58(3):136-41. PubMed ID: 10364909 [No Abstract] [Full Text] [Related]
37. Influenza and autoimmunity. Toplak N; Avcin T Ann N Y Acad Sci; 2009 Sep; 1173():619-26. PubMed ID: 19758207 [TBL] [Abstract][Full Text] [Related]
38. Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease. Prete M; Perosa F; Favoino E; Dammacco F Clin Exp Med; 2005 Dec; 5(4):141-60. PubMed ID: 16362794 [TBL] [Abstract][Full Text] [Related]
39. T-cell receptor-based immunointervention in autoimmune diseases. Therapeutic use of monoclonal antibodies. Chatenoud L; Bach JF Immunol Ser; 1993; 59():101-16. PubMed ID: 7681694 [No Abstract] [Full Text] [Related]